nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—SREBP signalling—AMFR—urinary bladder cancer	0.1	0.167	CbGpPWpGaD
Tyloxapol—LPL—prostate gland—urinary bladder cancer	0.0982	0.246	CbGeAlD
Tyloxapol—LPL—seminal vesicle—urinary bladder cancer	0.083	0.208	CbGeAlD
Tyloxapol—LPL—renal system—urinary bladder cancer	0.0669	0.168	CbGeAlD
Tyloxapol—LPL—urethra—urinary bladder cancer	0.0657	0.165	CbGeAlD
Tyloxapol—LPL—female reproductive system—urinary bladder cancer	0.0536	0.134	CbGeAlD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.0349	0.058	CbGpPWpGaD
Tyloxapol—LPL—lymph node—urinary bladder cancer	0.0313	0.0786	CbGeAlD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.0281	0.0467	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.0169	0.0281	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.0148	0.0246	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—NCOR1—urinary bladder cancer	0.0143	0.0237	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—FAS—urinary bladder cancer	0.0125	0.0208	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.0121	0.0202	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—CDK4—urinary bladder cancer	0.0113	0.0187	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PPARG—urinary bladder cancer	0.0112	0.0186	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.0106	0.0177	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARG—urinary bladder cancer	0.0102	0.017	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.0101	0.0168	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.00982	0.0163	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—CREBBP—urinary bladder cancer	0.00982	0.0163	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NCOR1—urinary bladder cancer	0.00938	0.0156	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.0088	0.0146	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00876	0.0146	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CNTN2—urinary bladder cancer	0.00862	0.0143	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.00861	0.0143	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—FAS—urinary bladder cancer	0.00841	0.014	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.0082	0.0136	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.00813	0.0135	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.00691	0.0115	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARG—urinary bladder cancer	0.00672	0.0112	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.00669	0.0111	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—RB1—urinary bladder cancer	0.00644	0.0107	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IGF1—urinary bladder cancer	0.00638	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Disease—GSTO2—urinary bladder cancer	0.00566	0.00941	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.00543	0.00903	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—urinary bladder cancer	0.00532	0.00885	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTZ1—urinary bladder cancer	0.005	0.00832	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTO2—urinary bladder cancer	0.00474	0.00788	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAT1—urinary bladder cancer	0.00474	0.00788	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—urinary bladder cancer	0.00469	0.0078	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00466	0.00775	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CDKN1A—urinary bladder cancer	0.00462	0.00769	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC19A1—urinary bladder cancer	0.0044	0.00732	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UGT2B7—urinary bladder cancer	0.00434	0.00721	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRSS3—urinary bladder cancer	0.00429	0.00713	CbGpPWpGaD
Tyloxapol—LPL—Disease—HDAC4—urinary bladder cancer	0.00409	0.00681	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP4B1—urinary bladder cancer	0.0039	0.00649	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC19A1—urinary bladder cancer	0.00369	0.00613	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRSS3—urinary bladder cancer	0.00359	0.00597	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—urinary bladder cancer	0.00357	0.00594	CbGpPWpGaD
Tyloxapol—LPL—Disease—LIG1—urinary bladder cancer	0.00325	0.00541	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCOR1—urinary bladder cancer	0.00322	0.00536	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00288	0.00479	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMP—urinary bladder cancer	0.00287	0.00478	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC4—urinary bladder cancer	0.00287	0.00477	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00276	0.00459	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAT2—urinary bladder cancer	0.0026	0.00432	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CDK4—urinary bladder cancer	0.00254	0.00423	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO2—urinary bladder cancer	0.00248	0.00412	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLI1—urinary bladder cancer	0.0024	0.00399	CbGpPWpGaD
Tyloxapol—LPL—Disease—RBX1—urinary bladder cancer	0.00235	0.00391	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—urinary bladder cancer	0.00231	0.00384	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—RRM2—urinary bladder cancer	0.00224	0.00373	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CREBBP—urinary bladder cancer	0.00222	0.00369	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAG1—urinary bladder cancer	0.0021	0.0035	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO2—urinary bladder cancer	0.00208	0.00345	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HPGDS—urinary bladder cancer	0.00208	0.00345	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00206	0.00343	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—urinary bladder cancer	0.00201	0.00335	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RHOA—urinary bladder cancer	0.00201	0.00334	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00198	0.0033	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—urinary bladder cancer	0.00186	0.00309	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NQO1—urinary bladder cancer	0.00167	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RBX1—urinary bladder cancer	0.00165	0.00274	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.00162	0.0027	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—urinary bladder cancer	0.00159	0.00265	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TSC1—urinary bladder cancer	0.00155	0.00257	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCOR1—urinary bladder cancer	0.00153	0.00255	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EP300—urinary bladder cancer	0.00151	0.00251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG1—urinary bladder cancer	0.00147	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—urinary bladder cancer	0.00147	0.00245	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERCC2—urinary bladder cancer	0.00144	0.00239	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.00142	0.00236	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—urinary bladder cancer	0.0014	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—urinary bladder cancer	0.00135	0.00225	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.00135	0.00225	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—urinary bladder cancer	0.00135	0.00224	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMS—urinary bladder cancer	0.0013	0.00216	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—urinary bladder cancer	0.00129	0.00214	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—urinary bladder cancer	0.00128	0.00213	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOR1—urinary bladder cancer	0.00128	0.00213	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR3—urinary bladder cancer	0.00124	0.00206	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—urinary bladder cancer	0.00123	0.00204	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—urinary bladder cancer	0.00123	0.00204	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—urinary bladder cancer	0.00122	0.00202	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ERCC2—urinary bladder cancer	0.00121	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—S100B—urinary bladder cancer	0.00119	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—urinary bladder cancer	0.00113	0.00189	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCOR1—urinary bladder cancer	0.00107	0.00178	CbGpPWpGaD
Tyloxapol—LPL—Disease—CREBBP—urinary bladder cancer	0.00105	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—urinary bladder cancer	0.00103	0.00172	CbGpPWpGaD
Tyloxapol—LPL—Disease—RHOA—urinary bladder cancer	0.000954	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—urinary bladder cancer	0.000945	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—urinary bladder cancer	0.000919	0.00153	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CREBBP—urinary bladder cancer	0.000883	0.00147	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—urinary bladder cancer	0.000883	0.00147	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR3—urinary bladder cancer	0.000867	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—urinary bladder cancer	0.000863	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ESR1—urinary bladder cancer	0.000843	0.0014	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—urinary bladder cancer	0.000755	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—urinary bladder cancer	0.000753	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CREBBP—urinary bladder cancer	0.000738	0.00123	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—urinary bladder cancer	0.000729	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—urinary bladder cancer	0.000723	0.0012	CbGpPWpGaD
Tyloxapol—LPL—Disease—EP300—urinary bladder cancer	0.000718	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—urinary bladder cancer	0.000698	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RHOA—urinary bladder cancer	0.000668	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—urinary bladder cancer	0.000631	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—urinary bladder cancer	0.000626	0.00104	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—urinary bladder cancer	0.000618	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—urinary bladder cancer	0.000612	0.00102	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—EP300—urinary bladder cancer	0.000601	0.001	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—urinary bladder cancer	0.000586	0.000975	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—urinary bladder cancer	0.000578	0.000962	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—urinary bladder cancer	0.00056	0.000932	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—urinary bladder cancer	0.000546	0.000909	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—urinary bladder cancer	0.00053	0.000882	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000529	0.000879	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—urinary bladder cancer	0.000527	0.000877	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EP300—urinary bladder cancer	0.000503	0.000836	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—urinary bladder cancer	0.000491	0.000817	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—urinary bladder cancer	0.000489	0.000813	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—urinary bladder cancer	0.000438	0.000729	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—urinary bladder cancer	0.000429	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—urinary bladder cancer	0.000405	0.000673	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—urinary bladder cancer	0.00036	0.000599	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—urinary bladder cancer	0.000344	0.000572	CbGpPWpGaD
